Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by McLachertyon Nov 05, 2010 10:19pm

142 Views

Post# 17667418

Thanks Ama

You were bang on as usual but I see the shares bought by last financing are now at play and holding down. It was nice to come up to the range we should be, although about 10 cents low in my opinion. Next news should spike nicely atlhough I woulld like to see us in at least 50s prior to next financing. I will follow your advice and once again thanks for the accurate posts. Jim GLTA

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver